India  
 
NewsR.in

Weight loss drug gets US nod to treat sleep apnea; India launch likely next year

IndiaTimes Tuesday, 24 December 2024 ()
The US FDA has approved the anti-diabetic drug Zepbound (Tirzepatide) for managing obstructive sleep apnea (OSA) in obese adults. Eli Lilly plans to launch the drug in India by 2025, pending approvals. The treatment is expected to be a breakthrough by aiding weight reduction, which in turn improves breathing during sleep.
0
shares		ShareTweetSavePostSend
 

You Might Like


💡 newsR Knowledge: Other News Mentions

Tirzepatide Tirzepatide Anti-diabetic and weight loss medication


Food and Drug Administration Food and Drug Administration United States federal agency


Eli Lilly and Company Eli Lilly and Company American pharmaceutical company


Related videos from verified sources

Jamie Foxx Gets Stitches After Birthday Dinner Altercation, Jane Seymour Flees Malibu Home Amidst Wildfires, Jelly Roll's 120lb [Video]

Jamie Foxx Gets Stitches After Birthday Dinner Altercation, Jane Seymour Flees Malibu Home Amidst Wildfires, Jelly Roll's 120lb

Jamie Foxx receives stitches after getting hit in the mouth with a glass at his birthday dinner. The actor required stitches after an altercation that took place while celebrating his 57th birthday on..

Credit: LifeMinute.tv     Duration: 01:00Published